GILEAD SCIENCES INC Insider Trading for May 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GILEAD SCIENCES INC for May 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 21.58 | 50,000 | 1,078,750 | 190,000 | |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 20.74 | 20,000 | 414,800 | 0 | |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 109.65 | 43,962 | 4,820,253 | 165,168 | 209.1 K to 165.2 K (-21.02 %) |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 109.12 | 26,038 | 2,841,280 | 209,130 | 235.2 K to 209.1 K (-11.07 %) |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 21.58 | 50,000 | 1,078,750 | 235,168 | 185.2 K to 235.2 K (+27.00 %) |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 20.74 | 20,000 | 414,800 | 185,168 | 165.2 K to 185.2 K (+12.11 %) |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Option Exercise | M | 23.60 | 625 | 14,750 | 4,375 | |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Option Exercise | M | 19.09 | 24,375 | 465,197 | 0 | |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 110.01 | 25,000 | 2,750,210 | 143,422 | 168.4 K to 143.4 K (-14.84 %) |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Buy | M | 23.60 | 625 | 14,750 | 168,422 | 167.8 K to 168.4 K (+0.37 %) |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Buy | M | 19.09 | 24,375 | 465,197 | 167,797 | 143.4 K to 167.8 K (+17.00 %) |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 80.65 | 4,074 | 328,568 | 26,566 | |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 1,926 | 78,119 | 15,597 | |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 110.00 | 6,000 | 660,020 | 47,632 | 53.6 K to 47.6 K (-11.19 %) |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 1,926 | 78,119 | 53,632 | 51.7 K to 53.6 K (+3.72 %) |
| May 19 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 80.65 | 4,074 | 328,568 | 51,706 | 47.6 K to 51.7 K (+8.55 %) |
| May 12 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 0.00 | 5,000 | 0 | 7,500 | |
| May 12 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Payment of Exercise | F | 103.85 | 2,807 | 291,507 | 47,632 | 50.4 K to 47.6 K (-5.57 %) |
| May 12 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 0.00 | 5,000 | 0 | 50,439 | 45.4 K to 50.4 K (+11.00 %) |
| May 11 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Option Exercise | M | 14.50 | 100,000 | 1,450,250 | 700,000 | |
| May 11 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 101.94 | 15,951 | 1,626,029 | 1,029,108 | 1 M to 1 M (-1.53 %) |
| May 11 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 101.03 | 57,310 | 5,789,829 | 1,045,059 | 1.1 M to 1 M (-5.20 %) |
| May 11 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 100.39 | 26,739 | 2,684,304 | 1,102,369 | 1.1 M to 1.1 M (-2.37 %) |
| May 11 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Buy | M | 14.50 | 100,000 | 1,450,250 | 1,129,108 | 1 M to 1.1 M (+9.72 %) |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | DAVIGNON ETIENNE | Director | Option Exercise | A | 102.27 | 5,167 | 528,429 | 5,167 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | DAVIGNON ETIENNE | Director | Option Exercise | A | 0.00 | 1,466 | 0 | 1,466 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | DAVIGNON ETIENNE | Director | Option Exercise | M | 0.00 | 1,904 | 0 | 0 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | DAVIGNON ETIENNE | Director | Payment of Exercise | F | 102.99 | 572 | 58,910 | 837,605 | 838.2 K to 837.6 K (-0.07 %) |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | DAVIGNON ETIENNE | Director | Buy | M | 0.00 | 1,904 | 0 | 838,177 | 836.3 K to 838.2 K (+0.23 %) |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | MADIGAN JOHN W | Director | Option Exercise | A | 102.27 | 5,167 | 528,429 | 5,167 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | MADIGAN JOHN W | Director | Option Exercise | A | 0.00 | 1,466 | 0 | 1,466 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | MADIGAN JOHN W | Director | Option Exercise | M | 0.00 | 1,904 | 0 | 0 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | MADIGAN JOHN W | Director | Buy | M | 0.00 | 1,904 | 0 | 15,295 | 13.4 K to 15.3 K (+14.22 %) |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | A | 102.27 | 5,167 | 528,429 | 5,167 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | A | 0.00 | 1,466 | 0 | 1,466 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | M | 0.00 | 1,904 | 0 | 0 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Buy | M | 0.00 | 1,904 | 0 | 42,769 | 40.9 K to 42.8 K (+4.66 %) |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | A | 0.00 | 1,466 | 0 | 19,349 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | A | 102.27 | 5,167 | 528,429 | 5,167 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | A | 102.27 | 5,167 | 528,429 | 5,167 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | A | 0.00 | 1,466 | 0 | 1,466 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 0.00 | 1,904 | 0 | 0 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 0.00 | 1,904 | 0 | 44,309 | 42.4 K to 44.3 K (+4.49 %) |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Option Exercise | A | 102.27 | 5,167 | 528,429 | 5,167 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Option Exercise | A | 0.00 | 1,466 | 0 | 1,466 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Option Exercise | M | 0.00 | 1,904 | 0 | 0 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Buy | M | 0.00 | 1,904 | 0 | 90,077 | 88.2 K to 90.1 K (+2.16 %) |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 102.27 | 5,167 | 528,429 | 5,167 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 1,466 | 0 | 1,466 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | M | 0.00 | 1,904 | 0 | 0 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | M | 19.63 | 21,720 | 426,364 | 0 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Buy | M | 0.00 | 1,904 | 0 | 39,265 | 37.4 K to 39.3 K (+5.10 %) |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Buy | M | 19.63 | 21,720 | 426,364 | 37,361 | 15.6 K to 37.4 K (+138.87 %) |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 102.27 | 5,167 | 528,429 | 5,167 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 1,466 | 0 | 3,370 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | HILLS CARLA A | Director | Option Exercise | A | 102.27 | 5,167 | 528,429 | 5,167 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | HILLS CARLA A | Director | Option Exercise | A | 0.00 | 1,466 | 0 | 1,466 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | HILLS CARLA A | Director | Option Exercise | M | 0.00 | 1,904 | 0 | 0 | |
| May 07 2015 | GILD | GILEAD SCIENCES IN ... | HILLS CARLA A | Director | Buy | M | 0.00 | 1,904 | 0 | 37,819 | 35.9 K to 37.8 K (+5.30 %) |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Option Exercise | M | 19.09 | 10,000 | 190,850 | 24,375 | |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 106.05 | 1,380 | 146,345 | 143,422 | 144.8 K to 143.4 K (-0.95 %) |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 105.47 | 1,677 | 176,865 | 144,802 | 146.5 K to 144.8 K (-1.14 %) |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 104.34 | 2,240 | 233,715 | 146,479 | 148.7 K to 146.5 K (-1.51 %) |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 103.23 | 6,703 | 691,945 | 148,719 | 155.4 K to 148.7 K (-4.31 %) |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Buy | M | 19.09 | 10,000 | 190,850 | 155,422 | 145.4 K to 155.4 K (+6.88 %) |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | M | 40.56 | 5,592 | 226,812 | 39,158 | |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | M | 24.30 | 11,250 | 273,319 | 33,750 | |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 106.02 | 5,200 | 551,314 | 27,724 | 32.9 K to 27.7 K (-15.79 %) |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 105.33 | 5,742 | 604,787 | 32,924 | 38.7 K to 32.9 K (-14.85 %) |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 104.23 | 3,700 | 385,643 | 38,666 | 42.4 K to 38.7 K (-8.73 %) |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 103.48 | 2,200 | 227,661 | 42,366 | 44.6 K to 42.4 K (-4.94 %) |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Buy | M | 40.56 | 5,592 | 226,812 | 44,566 | 39 K to 44.6 K (+14.35 %) |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Buy | M | 24.30 | 11,250 | 273,319 | 38,974 | 27.7 K to 39 K (+40.58 %) |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 14.50 | 150,000 | 2,175,375 | 1,050,000 | |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 105.97 | 35,200 | 3,730,214 | 4,255,876 | 4.3 M to 4.3 M (-0.82 %) |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 105.21 | 66,159 | 6,960,330 | 4,291,076 | 4.4 M to 4.3 M (-1.52 %) |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 104.05 | 34,241 | 3,562,841 | 4,357,235 | 4.4 M to 4.4 M (-0.78 %) |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 103.41 | 14,400 | 1,489,105 | 4,391,476 | 4.4 M to 4.4 M (-0.33 %) |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 14.50 | 150,000 | 2,175,375 | 4,405,876 | 4.3 M to 4.4 M (+3.52 %) |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 80.65 | 2,000 | 161,300 | 30,640 | |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 103.18 | 2,000 | 206,365 | 45,439 | 47.4 K to 45.4 K (-4.22 %) |
| May 05 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 80.65 | 2,000 | 161,300 | 47,439 | 45.4 K to 47.4 K (+4.40 %) |